Mi Young Jang

Title: Mi Young Jang: Innovator in Androgen Receptor Research

Introduction

Mi Young Jang is a notable inventor based in Ansan, South Korea. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds targeting androgen receptors. Her work is crucial for advancing treatments for AR-related diseases.

Latest Patents

Mi Young Jang holds a patent for a substituted piperidine compound, which is designed to degrade androgen receptors. The patent details a compound of Chemical Formula 1, where X is CR, or a pharmaceutically acceptable salt thereof. This compound has potential medical applications for the treatment or prophylaxis of diseases related to androgen receptors. The patent also outlines methods for administering the compound effectively to subjects in need.

Career Highlights

Mi Young Jang is currently associated with Ubix Therapeutics, Inc., where she continues her research and development efforts. Her innovative work in the pharmaceutical industry has positioned her as a key figure in the fight against AR-related diseases.

Collaborations

Mi Young Jang collaborates with talented colleagues, including Ji Youn Park and Je Ho Ryu. These partnerships enhance the research environment and contribute to the advancement of their shared goals in medicinal chemistry.

Conclusion

Mi Young Jang's contributions to the field of androgen receptor research exemplify her dedication to innovation and the development of effective treatments. Her work continues to inspire advancements in medical science.